Filtered By:
Management: Government
This page shows you your search results in order of relevance. This is page number 20.
Order by Relevance | Date
Total 334 results found since Jan 2013.
With All Eyes on BA.2, Here ’s What Experts Say Might Happen in the U.S.
For the last two years, the U.S. has been stuck in a cycle of COVID-19 case spikes and lulls. Cases rise dramatically, then drop off—and the process repeats.
Several times, these surges have been preceded by rising case rates in Europe—such as before last year’s Delta wave and the start of last winter’s Omicron spike—which is why experts have been carefully monitoring a recent increase in cases there. More than 5.2 million COVID-19 infections were reported across Europe during the week ending March 20, according to World Health Organization data, and countries including the U.K. have also repo...
Source: TIME: Health - March 25, 2022 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized COVID-19 healthscienceclimate Source Type: news
Defining the risk of SARS-CoV-2 variants on immune protection
We report the development of reagents, methodologies, models, and pivotal findings facilitated by this collaborative approach and identify future challenges. This program serves as a template for the response against rapidly evolving pandemic pathogens by monitoring viral evolution in the human population to identify variants that could erode the effectiveness of countermeasures.PMID:35361968 | DOI:10.1038/s41586-022-04690-5
Source: Cancer Control - April 1, 2022 Category: Cancer & Oncology Authors: Marciela M DeGrace Elodie Ghedin Matthew B Frieman Florian Krammer Alba Grifoni Arghavan Alisoltani Galit Alter Rama R Amara Ralph S Baric Dan H Barouch Jesse D Bloom Louis-Marie Bloyet Gaston Bonenfant Adrianus C M Boon Eli A Boritz Debbie L Bratt Traci Source Type: research
Tim Kaine Refuses to Let Long COVID Be an Afterthought
When Virginia Sen. Tim Kaine came down with a “blizzard” of allergy-like symptoms in March 2020, he blamed the layer of pollen coating his car. “It was Washington, D.C., in late March,” he says. I thought, “‘Okay, well, this is hay fever gone wild.’”
Only when his wife, Anne Holton, developed “textbook” COVID-19 symptoms did Kaine start to wonder if he might have the new virus, the subject of the massive economic assistance bill—the CARES Act—that he and other lawmakers were then working to pass. Testing at that time was hard to come by, even for Hill...
Source: TIME: Health - May 4, 2022 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized COVID-19 feature Source Type: news
News at a glance: China ’s carbon pledge, ARPA-H’s interim head, and an exascale computer
Some content has been removed for formatting reasons. Please view the original article for the best reading experience.
Table of contents
A version of this story appeared in Science, Vol 376, Issue 6597.
Download PDF
CONSERVATION
U.S. moves to stop Alaska copper mine
The U.S. Environmental Protection Agency (EPA) is moving to block construction of a massive copper and gold mine that would risk polluting the headwaters of Alaska’s Bristol Bay, home to the world’s largest sockeye salmon runs. EPA announced last week it plans to forbid dis...
Source: Science of Aging Knowledge Environment - June 2, 2022 Category: Geriatrics Source Type: research
Dr. Anthony Fauci Tests Positive for COVID-19 With Mild Symptoms
Dr. Anthony Fauci, the face of America’s pandemic response through two White House administrations, has tested positive for the coronavirus.
The 81-year-old Fauci, who is fully vaccinated and has received two booster shots, was experiencing mild COVID-19 symptoms, according to a statement Wednesday from the National Institutes of Health.
Fauci has not recently been in close contact with President Joe Biden or other senior government officials. He tested positive on a rapid antigen test. He is following public health guidelines and his doctor’s advice, and will return to work at the NIH when he tests negative, a...
Source: TIME: Health - June 15, 2022 Category: Consumer Health News Authors: Carla K. Johnson / AP Tags: Uncategorized COVID-19 healthscienceclimate News Desk wire Source Type: news
There ’s a shortage of monkeypox vaccine. Could one dose instead of two suffice?
As the monkeypox outbreak grows, the preferred vaccine to combat it is in short supply—a problem that’s only getting worse now that countries are expanding access to the vaccine. But there is a strategy that could double overnight the number of people who can be vaccinated: use a single shot instead of the recommended two.
Compelling data from monkey and human studies suggest a single dose of the vaccine—produced by Bavarian Nordic and sold under three different brand names—solidly protects against monkeypox, and that the second dose mainly serves to extend the durability of protection.
The United Kingdom...
Source: Science of Aging Knowledge Environment - July 1, 2022 Category: Geriatrics Source Type: research
Dr. Anthony Fauci Expected to Retire By the End of Biden ’ s Current Term
WASHINGTON — Dr. Anthony Fauci, the government’s top infectious disease expert, said Monday he plans to retire by the end of President Joe Biden’s term in January 2025.
Fauci, 81, was appointed director of the National Institute of Allergy and Infectious Diseases in 1984, and has led research in HIV/AIDS, respiratory infections, Ebola, Zika and the coronavirus. He has advised seven presidents and is Biden’s chief medical adviser.
In an interview with Politico, Fauci said he hoped to “leave behind an institution where I have picked the best people in the country, if not the world, who will cont...
Source: TIME: Health - July 18, 2022 Category: Consumer Health News Authors: Associated Press Tags: Uncategorized Source Type: news
Fauci says he will retire from government post by the end of Biden’s term
Anthony S. Fauci, President Biden’s chief medical adviser, has served as director of the National Institute of Allergy and Infectious Diseases since 1984.
Source: Washington Post: To Your Health - July 18, 2022 Category: Consumer Health News Authors: Yasmeen Abutaleb Source Type: news
Why efforts to make better, more universal coronavirus vaccines are struggling
There’s a new call from the White House to develop vaccines that might protect against future SARS-CoV-2 mutants or even unknown coronaviruses. “The vaccines we have are terrific, but we can do better than terrific,” Ashish Jha, White House COVID-19 response coordinator, said at a vaccine summit yesterday that gathered researchers, companies, and government officials. “Ultimately, we need vaccines that can protect us no matter what Mother Nature throws at us.”
But no specific funding request to Congress was revealed at the summit, or any concrete plans, so vaccine developers and the public shouldn’t expect...
Source: Science of Aging Knowledge Environment - July 27, 2022 Category: Geriatrics Source Type: research
UCLA awarded $11.5 million to improve organ, hand and face transplantation
The Dumont –UCLA Transplant Center has received two grants totaling $11.5 million from the federal government for research aimed at making donated organs last longer and helping transplant recipients live longer, healthier lives.The grant projects — one funded by the National Institutes of Health and the other by the Department of Defense — focus specifically on improving outcomes in liver transplantation and in hand and face transplantation.Both initiatives are led by Dr. Jerzy Kupiec-Weglinski, UCLA ’s Paul I. Terasaki Professor of Surgery and vice chair of basic research in the surgery department at theDavid Gef...
Source: UCLA Newsroom: Health Sciences - July 29, 2022 Category: Universities & Medical Training Source Type: news
How Worried Should We Be About the Monkeypox Health Emergency? How Worried Should We Be About the Monkeypox Health Emergency?
The US declared the monkeypox outbreak a public health emergency, a move that may allow the government new avenues for increasing production and use of existing vaccines.Reuters Health Information
Source: Medscape Allergy Headlines - August 5, 2022 Category: Allergy & Immunology Tags: Infectious Diseases News Source Type: news
What to Know About the Monkeypox Drug TPOXX —And Why It ’ s So Hard to Get
Monkeypox, which federal officials declared a public health emergency on August 4, is not as contagious as the other ongoing public health emergency in the U.S.: COVID-19. Monkeypox primarily spreads through contact with infected skin lesions. Theoretically, containing monkeypox should therefore be more feasible, as long as testing, vaccines, and treatments are accessible. But in reality, the rollouts of all three approaches have faced major challenges. Getting the antiviral drug tecovirimat, also known as TPOXX, is particularly difficult.
Here’s what to know about the antiviral drug treatment TPOXX.
What is TPOXX?
T...
Source: TIME: Health - August 9, 2022 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized healthscienceclimate monkeypox Source Type: news
Your Kid ’ s School Needs Better Ventilation to Help Keep COVID-19 in Check
Across the country, K-12 schools are starting their next year of classes in the middle of a COVID-19 surge. As the BA.5 Omicron subvariant drives thousands of reinfections, schools have largely put aside safety measures like mask requirements and physical distancing.
In response, some parents and experts are trying to improve ventilation in schools, since better air quality in buildings can reduce COVID-19’s spread and even improve other health outcomes. But, despite readily available resources—including millions of dollars in funding from the federal government—many schools have not invested in upgrading...
Source: TIME: Health - August 16, 2022 Category: Consumer Health News Authors: Betsy Ladyzhets Tags: Uncategorized biztech2030 COVID-19 healthscienceclimate Source Type: news
Fauci Says He Will Step Down in December to Pursue His ‘Next Chapter’
Dr. Anthony S. Fauci, who has advised seven presidents and spent more than half a century at the National Institutes of Health, will leave government service by the end of the year.
Source: NYT Health - August 22, 2022 Category: Consumer Health News Authors: Sheryl Gay Stolberg Tags: Fauci, Anthony S National Institute of Allergy and Infectious Diseases National Institutes of Health Appointments and Executive Changes Government Employees United States Politics and Government Coronavirus (2019-nCoV) Biden, Joseph R Jr T Source Type: news
He battled AIDS, COVID-19, and Trump. Now, Anthony Fauci is stepping down
Anthony Fauci, the renowned physician-scientist who has led the $6.3 billion National Institute of Allergy and Infectious Diseases (NIAID) for nearly 4 decades and since early 2020 has been the U.S. government’s voice of scientific reason during the COVID-19 pandemic, will step down from government service in December.
Fauci, 81, had said in
recent interviews
that he planned to retire from the government by the end of President Joe Biden’s administration, but did not give a date until today. He said in a
statement
that although leading NIAID “has been the honor of a lifetime,” he plans to “pursue...
Source: Science of Aging Knowledge Environment - August 22, 2022 Category: Geriatrics Source Type: research
